Prime award
LEIDOS BIOMEDICAL RESEARCH INC · Department of Health and Human Services
CHARACTERIZING THE MECHANISM OF ACTION (MOA) OF INVESTIGATIONAL/APPROVED CANCER AGENTS
Current value$5.66M
Obligated to date$0
Months remaining24
Sign in to mark this as watching, pursuing, or passed — and to be told when its end date changes.
Recompete signal
This award ends in 24 months.
Award record
| Field | Value |
|---|---|
| Recipient | LEIDOS BIOMEDICAL RESEARCH INC |
| Awarding agency | Department of Health and Human Services |
| NAICS | 541715 |
| PSC | AN12 |
| Place of performance | MD |
| Period | → Sep 21, 2028 |
| Competition | A |
| Vehicle | Standalone |
Data & sources
Record as published by USAspending.gov, vintage FY2021–FY2025 full archives · USAspending.gov, retrieved Aug 6, 2026. Values change as modifications are reported; obligations may be negative when work is de-obligated.